Back to top
more

Molina Healthcare (MOH)

(Real Time Quote from BATS)

$307.87 USD

307.87
257,592

-1.43 (-0.46%)

Updated Nov 14, 2024 12:50 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (85 out of 250)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Here's How Much a $1000 Investment in Molina Made 10 Years Ago Would Be Worth Today

by Zacks Equity Research

Holding on to popular or trending stocks for the long-term can make your portfolio a winner.

Molina (MOH) Up 3.5% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Molina (MOH) is a Top Value Stock for the Long-Term

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here is Why Growth Investors Should Buy Molina (MOH) Now

by Zacks Equity Research

Molina (MOH) is well positioned to outperform the market, as it exhibits above-average growth in financials.

UnitedHealth (UNH) Wins Medicaid Deal to Serve New Mexicans

by Zacks Equity Research

UnitedHealth (UNH) receives a contract from the New Mexico HSD, subsequent to which it can effectively serve the statewide Medicaid members.

Molina Healthcare (MOH) Wins Medicaid Deal From New Mexico HSD

by Zacks Equity Research

Molina Healthcare (MOH) receives a contract from the New Mexico HSD, subsequent to which it can effectively serve the statewide Medicaid members.

Sumit Singh headshot

Add These 4 Stocks With Impressive Interest Coverage Ratio

by Sumit Singh

A company that is capable of generating earnings well above its interest expense can withstand financial hardship. MOH, DAL, ATO and MCK are strong enough to meet financial obligations.

Acadia Healthcare (ACHC) Q2 Earnings Beat on Higher Admissions

by Zacks Equity Research

Acadia Healthcare's (ACHC) Q2 results indicate improved patient days and revenue per patient day. Management expects 2023 adjusted EPS of $3.25-$3.50.

Molina (MOH) Q2 Earnings Beat on High Premiums, '23 View Raised

by Zacks Equity Research

Molina Healthcare's (MOH) second-quarter results are aided by increased membership, and Medicaid and Medicare strength.

Molina (MOH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

Although the revenue and EPS for Molina (MOH) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Molina (MOH) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Molina (MOH) delivered earnings and revenue surprises of 11.88% and 0.52%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Will High Medical Costs Hurt Molina Healthcare's (MOH) Q2 Earnings?

by Zacks Equity Research

Molina Healthcare's (MOH) Q2 results are likely to reflect the membership growth in its Medicaid and Medicare business units, partly offset by an elevated medical cost level.

Centene (CNC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Centene (CNC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Molina (MOH) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Molina (MOH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Molina (MOH) to Buy Bright Health's California Medicare Business

by Zacks Equity Research

Molina's (MOH) Brand New Day and Central Health Plan of California buyout complements Molina's Medicaid footprint and aligns with its 2024 Medi-Cal plan.

Looking for a Growth Stock? 3 Reasons Why Molina (MOH) is a Solid Choice

by Zacks Equity Research

Molina (MOH) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Should Value Investors Buy Humana (HUM) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Here's Why You Should Retain Molina (MOH) in Your Portfolio

by Zacks Equity Research

Numerous contract wins, financial flexibility and strong performing Medicaid and Medicare segments poise Molina (MOH) well for growth.

Here's How Much You'd Have If You Invested $1000 in Molina a Decade Ago

by Zacks Equity Research

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

Kaibalya Pravo Dey headshot

U.S. Health Insurers Are Tumbling: Should You be Worried?

by Kaibalya Pravo Dey

Demand for procedures like hip and knee surgeries is rising, which will leave fewer premiums in hand after paying for the procedures for the health insurers.

UnitedHealth (UNH) Falls 6.4% on Cost Woes of Resumed Surgeries

by Zacks Equity Research

UnitedHealth's (UNH) Optum Health unit is likely to witness higher utilization, especially in ambulatory surgery operations.

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Industry Outlook Highlights UnitedHealth Group, The Cigna Group, Humana, Centene Corporation and Molina Healthcare

by Zacks Equity Research

UnitedHealth Group, The Cigna Group, Humana, Centene Corporation and Molina Healthcare are part of the Zacks Industry Outlook article.